| Peako Limited (PKO) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
25 Jul 2025 8:55AM |
$0.003 |
$0.004 |
risen by
60%
|
|
PKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Peako Limited continued exploration at the Eastman PGE Project with RC drilling completed during the quarter.
- Significant geochemical anomalies identified, supporting potential for further mineralisation.
- Results from drilling indicate broad PGE zones, prompting further exploration and metallurgical test work.
- Financial statements indicate $1.1 million cash at quarter end and manageable outflows for ongoing activities.
- No mining production or development activities were carried out during the quarter.
- Planned activities include additional geochemical sampling, heritage surveys, and metallurgical studies.
- The company remains in compliance with ASX Listing Rule 5.3.5 regarding director payments.
- No related party loans or guarantees were provided or received during the quarter.
- The report includes a summary of expenditure for exploration and evaluation, staff, and administration costs.
- Appendix 5B details cash flows for the period, including receipts, payments, and net change in cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sultan Resources Limited (SLZ) ORDINARY FULLY PAID |
Materials |
$5 |
Application for quotation of securities - SLZ
|
25 Jul 2025 8:55AM |
$0.006 |
$0.009 |
risen by
50%
|
|
| Sultan Resources Limited (SLZ) ORDINARY FULLY PAID |
Materials |
$5 |
Completion of Rights Issue and Shortfall Notification
|
25 Jul 2025 8:54AM |
$0.006 |
$0.009 |
risen by
50%
|
|
| Tesoro Gold Ltd (TSO) ORDINARY FULLY PAID |
Materials |
$233 |
Quarterly Activities Report
|
25 Jul 2025 8:52AM |
$0.031 |
$1.310 |
risen by
4,125.81%
|
|
TSO - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Scoping Study for El Zorro Gold Project in Chile
- Resource expansion drilling program commenced and applications submitted
- Successful capital raising activities during the quarter
- Focus on environmental and community engagement initiatives
- Financial position strengthened with cash reserves reported
- Preparation for Pre-Feasibility Study underway
- Permitting and regulatory processes progressing
- Strategic planning for further exploration and development
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$380 |
Update - Notification of buy-back - RG8
|
25 Jul 2025 8:52AM |
$2.050 |
$2.590 |
risen by
26.34%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$480 |
Update - Notification of buy-back - VG1
|
25 Jul 2025 8:51AM |
$1.760 |
$1.950 |
risen by
10.80%
|
|
| Tanami Gold NL (TAM) ORDINARY FULLY PAID |
Materials |
$83 |
First Results 2025 Field Season
|
25 Jul 2025 8:50AM |
$0.059 |
$0.071 |
risen by
20.34%
|
|
TAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Tanami Gold NL commenced the 2025 field season at the Tanami Joint Venture.
- Initial fieldwork focused on drilling and surface sampling at high-priority targets within the Central Tanami Project.
- Encouraging early gold mineralization results were reported from initial exploration activities.
- The exploration program is undertaken in partnership with Northern Star Resources Limited.
- The Central Tanami Project is a strategic focus for the ongoing exploration program.
- Systematic exploration is ongoing with plans for resource updates following the 2025 season.
- The report discusses the operational progress, initial results, and future plans for the field season.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vysarn Limited (VYS) ORDINARY FULLY PAID |
Materials |
$332 |
Hazen Heads of Agreement
|
25 Jul 2025 8:49AM |
$0.550 |
$0.630 |
risen by
14.55%
|
|
| Sierra Nevada Gold Inc. (SNX) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Materials |
$13 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
25 Jul 2025 8:48AM |
$0.020 |
$0.027 |
risen by
35%
|
|
SNX - Price-sensitive ASX Announcement
Full Release
Key Points
- SNX continued exploration at its New Pass, Rozan, and Blackhawk projects in Nevada.
- Results from drilling and geophysical surveys were reported, with ongoing analysis and interpretation.
- Permitting processes for additional drilling and exploration advances were updated.
- The company maintains a focus on gold and copper targets in Nevada.
- Financial summary shows cash outflows for exploration and administrative costs.
- Cash balance and funding position at the end of the quarter are provided.
- Appendix 5B cash flow report is included for compliance with ASX listings.
- Forward-looking plans for further drilling and exploration are indicated.
- Compliance statements and disclosures in line with ASX requirements are present.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$8,884 |
424b3 Prospectus - Amcor Flexibles North America
|
25 Jul 2025 8:46AM |
$14.870 |
$12.730 |
fallen by
14.39%
|
|
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$84 |
Section 708A Notice
|
25 Jul 2025 8:44AM |
$0.530 |
$0.455 |
fallen by
14.15%
|
|
| Steadfast Group Limited (SDF) ORDINARY FULLY PAID |
Financials |
$5,838 |
Appointment of Company Secretary
|
25 Jul 2025 8:42AM |
$5.910 |
$5.250 |
fallen by
11.17%
|
|
| Cromwell Property Group (CMW) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,257 |
Details of FY25 Results Briefing
|
25 Jul 2025 8:42AM |
$0.405 |
$0.480 |
risen by
18.52%
|
|
| DeSoto Resources Limited (DES) ORDINARY FULLY PAID |
Materials |
$47 |
Two Rigs Now Drilling at Spectrum
|
25 Jul 2025 8:42AM |
$0.175 |
$0.170 |
fallen by
2.86%
|
|
DES - Price-sensitive ASX Announcement
Full Release
Key Points
- DeSoto Resources Limited now has two drill rigs operating at the Spectrum Project.
- The Spectrum Project is located in the Northern Territory and is prospective for gold.
- The expanded drilling program aims to accelerate exploration and resource definition.
- Current activities are focused on following up recent drilling successes.
- Multiple drill targets are being tested as part of this campaign.
- The company is committed to systematic exploration and advancing the project.
- The announcement was released on 6 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rapid Critical Metals Limited (RCM) ORDINARY FULLY PAID |
Materials |
$56 |
Silver Acquisition Completion & Appointment of New MD
|
25 Jul 2025 8:42AM |
$0.029 |
$0.048 |
risen by
65.52%
|
|
RCM - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of a significant silver asset acquisition by Rapid Critical Metals Limited.
- Appointment of a new Managing Director to lead the company.
- The acquisition is expected to enhance the company's portfolio and growth prospects.
- Background information provided on the new Managing Director and his industry experience.
- The company reinforces its strategy to focus on critical and precious metals.
- Shareholders and stakeholders are anticipated to benefit from the transaction.
- The announcement aligns with Rapid Critical Metals Limited's long-term growth objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Income Maximiser Limited (WMX) ORDINARY FULLY PAID |
Financials |
$306 |
Notice of Extraordinary General Meeting and Proxy Form
|
25 Jul 2025 8:41AM |
$1.675 |
$1.585 |
fallen by
5.37%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$70 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
25 Jul 2025 8:41AM |
$0.480 |
$0.800 |
risen by
66.67%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clinical validation studies advanced in the United States and Europe.
- Key milestones achieved in the development and deployment of digital diagnostic technology.
- New partnerships and expanded research collaborations reported.
- Operational expenditure focused on research and development, administration, and staffing.
- Cash flow position and funding outcomes disclosed as per ASX requirements.
- Ongoing focus on commercialization of digital diagnostics for neurological and psychiatric disorders.
- Report includes Appendix 4C as mandated by the ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$620 |
Update - Notification of buy-back - FPR
|
25 Jul 2025 8:40AM |
$2.820 |
$2.870 |
risen by
1.77%
|
|
| Far Limited (FAR) ORDINARY FULLY PAID |
Energy |
$38 |
Quarterly Activities Report and Appendix 5B
|
25 Jul 2025 8:37AM |
$0.410 |
$0.415 |
risen by
1.22%
|
|
FAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Far Limited issued its Quarterly Activities Report and Appendix 5B for the quarter ended 31 December 2023.
- The company maintained focus on oil and gas exploration and development, primarily in Africa.
- Efforts to maximise shareholder value included asset management, cost reductions, and the pursuit of new business opportunities.
- The report highlights ongoing financial discipline with cash flow management and expenditure controls.
- Updates provided on significant projects and divestment activities.
- Appendix 5B presents details of cash flows, operational spending, and investment transactions for the quarter.
- The report complies with the reporting requirements of the Australian Securities Exchange (ASX).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$125 |
Change of Director's Interest Notice - JC
|
25 Jul 2025 8:36AM |
$0.170 |
$0.465 |
risen by
173.53%
|
|
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$35,495 |
Update - Notification of buy-back - ALL
|
25 Jul 2025 8:36AM |
$67.450 |
$57.540 |
fallen by
14.69%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$336 |
Quarterly Appendix 4C and Activities Report
|
25 Jul 2025 8:35AM |
$0.550 |
$0.560 |
risen by
1.82%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- Dimerix Limited (DXB) released its Appendix 4C and Quarterly Activities Report for the quarter ending 31 March 2024.
- The company continued progression of its Phase 3 ACTION3 clinical trial evaluating DMX-200 in patients with FSGS kidney disease, maintaining recruitment momentum across global sites.
- Dimerix reported continued engagement with regulators and key opinion leaders to advance development and commercial pathways for DMX-200.
- The company highlighted strategic partnerships, with the FSGS trial being conducted under an agreement with the global pharmaceutical company Advanz Pharma.
- Cash receipts from customers for the quarter totaled $0.09 million, with net cash used in operating activities at $4.13 million.
- Dimerix ended the quarter with a cash balance of $7.14 million, which is expected to fund ongoing operations and clinical development.
- No revenue was generated from product sales during the period, with cash outflows primarily related to research, development, and clinical trial activities.
- The company continued to evaluate additional opportunities for its DMX-200 asset, including in other kidney diseases and acute respiratory distress syndrome (ARDS).
- Payments to related parties and their associates during the quarter amounted to $0.19 million, covering directors’ fees, salaries, and consulting services.
- Dimerix remains focused on executing its clinical and commercial strategies, with a view to delivering value to shareholders and addressing unmet medical needs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$232 |
Notification of buy-back - IMB
|
25 Jul 2025 8:35AM |
$0.485 |
$0.615 |
risen by
26.80%
|
|
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$58 |
CFO Transition
|
25 Jul 2025 8:34AM |
$0.850 |
$0.735 |
fallen by
13.53%
|
|
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$84 |
Notification regarding unquoted securities - MTH
|
25 Jul 2025 8:32AM |
$0.530 |
$0.455 |
fallen by
14.15%
|
|
Call 1300 880 160
Start a chat
Schedule a call
